Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Chemokines as Cancer Vaccine Adjuvants.

Bobanga ID, Petrosiute A, Huang AY.

Vaccines (Basel). 2013 Dec 1;1(4):444-462.

PMID:
24967094
[PubMed]
Free PMC Article
2.

One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment.

Yang X, Hou J, Han Z, Wang Y, Hao C, Wei L, Shi Y.

Cell Biosci. 2013 Jan 21;3(1):5. doi: 10.1186/2045-3701-3-5.

PMID:
23336752
[PubMed]
Free PMC Article
3.

Screen and analysis of key disease genes for precancerous lesions of oral buccal mucosa induced by DMBA in golden hamsters.

Chen D, Yang K, Zhang G, Mei J, Xiang L.

Oncol Lett. 2011 Mar;2(2):265-271. Epub 2010 Dec 23.

PMID:
22866075
[PubMed]
Free PMC Article
4.

CCR6 is not necessary for functional effects of human CCL18 in a mouse model.

Luzina IG, Atamas SP.

Fibrogenesis Tissue Repair. 2012 Jan 18;5(1):2. doi: 10.1186/1755-1536-5-2.

PMID:
22257697
[PubMed]
Free PMC Article
5.

Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.

Lietz R, Bayer W, Ontikatze T, Johrden L, Tenbusch M, Storcksdieck Genannt Bonsmann M, Uberla K, Dittmer U, Wildner O.

J Virol. 2012 Feb;86(3):1706-16. doi: 10.1128/JVI.06244-11. Epub 2011 Nov 16.

PMID:
22090142
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Chemokines in health and disease.

Raman D, Sobolik-Delmaire T, Richmond A.

Exp Cell Res. 2011 Mar 10;317(5):575-89. doi: 10.1016/j.yexcr.2011.01.005. Epub 2011 Jan 9. Review.

PMID:
21223965
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Local hyperthermia decreases the expression of CCL-20 in condyloma acuminatum.

Wang X, Gao XH, Hong Y, Li X, Chen HD.

Virol J. 2010 Nov 4;7:301. doi: 10.1186/1743-422X-7-301.

PMID:
21050487
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.

Song EY, Shurin MR, Tourkova IL, Gutkin DW, Shurin GV.

Cancer Res. 2010 Jun 1;70(11):4394-401. doi: 10.1158/0008-5472.CAN-10-0427. Epub 2010 May 11.

PMID:
20460540
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.

Radkevich-Brown O, Piechocki MP, Back JB, Weise AM, Pilon-Thomas S, Wei WZ.

Cancer Immunol Immunother. 2010 Mar;59(3):409-17. doi: 10.1007/s00262-009-0760-1.

PMID:
19730859
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Interaction between CXCR4 and CCL20 pathways regulates tumor growth.

Beider K, Abraham M, Begin M, Wald H, Weiss ID, Wald O, Pikarsky E, Abramovitch R, Zeira E, Galun E, Nagler A, Peled A.

PLoS One. 2009;4(4):e5125. doi: 10.1371/journal.pone.0005125. Epub 2009 Apr 2.

PMID:
19340288
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Chemokines and the microenvironment in neuroectodermal tumor-host interaction.

Somasundaram R, Herlyn D.

Semin Cancer Biol. 2009 Apr;19(2):92-6. doi: 10.1016/j.semcancer.2008.11.002. Epub 2008 Nov 13. Review.

PMID:
19049876
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Role of chemokines in tumor growth.

Raman D, Baugher PJ, Thu YM, Richmond A.

Cancer Lett. 2007 Oct 28;256(2):137-65. Epub 2007 Jul 12. Review.

PMID:
17629396
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Clinical utilization of chemokines to combat cancer: the double-edged sword.

Dell'Agnola C, Biragyn A.

Expert Rev Vaccines. 2007 Apr;6(2):267-83. Review.

PMID:
17408375
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

Intratumoral immunotherapy: using the tumour against itself.

Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ.

Immunology. 2005 Jan;114(1):11-22. Review.

PMID:
15606790
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.

Furumoto K, Soares L, Engleman EG, Merad M.

J Clin Invest. 2004 Mar;113(5):774-83.

PMID:
14991076
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk